tiprankstipranks
Advertisement
Advertisement
Fulcrum Therapeutics downgraded to Underweight from Overweight at JPMorgan
PremiumThe FlyFulcrum Therapeutics downgraded to Underweight from Overweight at JPMorgan
2M ago
Goldman suspends rating on Fulcrum Therapeutics
Premium
The Fly
Goldman suspends rating on Fulcrum Therapeutics
2M ago
Midday Fly By: Berkshire investing in Alphabet AI buildout
Premium
The Fly
Midday Fly By: Berkshire investing in Alphabet AI buildout
2M ago
Fein Slashes Fulcrum Price Target to $3 and Maintains Hold as Pociredir Shutdown Shifts Focus to Cash and Strategic Options
PremiumRatingsFein Slashes Fulcrum Price Target to $3 and Maintains Hold as Pociredir Shutdown Shifts Focus to Cash and Strategic Options
2M ago
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Fulcrum Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe FlyFulcrum Therapeutics downgraded to Hold from Buy at Stifel
2M ago
Fulcrum Therapeutics Ends Pociredir, Begins Strategic Review
Premium
Company Announcements
Fulcrum Therapeutics Ends Pociredir, Begins Strategic Review
2M ago
Fulcrum discontinues pociredir program in SCD, initiates strategic review
Premium
The Fly
Fulcrum discontinues pociredir program in SCD, initiates strategic review
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100